How do we reimagine support in the first year after pregnancy?
That question is at the heart of Hey Aunty! - a digital platform being developed by @McMasterU graduate student Vedha Viyas Thilagarajan under the supervision of Rohan D’Souza.
Learn more: https://t.co/6ot2Iwm0gw
Dr. Rohan D'Souza (@SingingOB) leads CaNCaM-Preg, which is focused on preventing, monitoring and reducing devastating cardiovascular events during pregnancy.
Funded with $5M, this initiative will contribute to improving maternal healthcare in Canada.
#HeartandStrokeScience
Studies on cardiac disease in #pregnancy have defined outcomes differently, reported selectively, and often missed what matters most to patients. COSCarP identifies 12 core outcomes and 12 checklist items to support consistency and relevance.
Learn more: https://t.co/1bCu8d8Ym5.
The second in a series of core outcome sets for high-risk pregnancy conditions developed through consensus with families with lived experience and healthcare professionals published in @CircOutcomes. Thank you @RizwanaAsh@CandiceSilvers1@IsabelleMalhame
@SingingOB receiving the CPP2025 award for outstanding contributions to the field if cardiac disease and pregnancy from @CandiceSilvers1@uelkayam and Dr Avraham Shotan. In Vienna
Congratulations to Rohan D'Souza, associate professor in the departments of Obstetrics & Gynecology and HEI, on receiving the CPP 2025 Award for Outstanding Contributions to the Field of Pregnancy and Heart Disease. Access the story: https://t.co/YDIxyYtCJ0 @SingingOB
This first article in a seven part series presents an overview of the essential elements of the GRADE approach that has proved useful in systematic reviews, health technology assessment reports, and clinical practice guidelines
https://t.co/rzV7gJl35l
With the world falling apart around us so grateful to spend a few sacred hours with the SERENE team. Amazed and grateful for the groundbreaking work on Maternal Morbidity. Thank you for continuing to lead our Dept and Canada @SingingOB@GiuliaMuraca1
Big news for #EBM! Just out in #BMJ, ROBUST-RCT, pristinely developed, innovative, simple, user-friendly instrument for risk of bias assessment in #RCTs far superior to anything before, will become standard outside of Cochrane and in #Cochrane if they let folks use it.
https://t.co/iEROPshcRW
With the support of @BrainCanada and @CIHR_IRSC, two national research networks will each receive $5 million in funding to better understand women’s unique risk factors for heart disease and stroke, and to improve diagnosis and treatment.
Learn more: https://t.co/N2Woz7idfn.
Sincere thanks to @nasrin_javid, @tashfromoz, @alisha_adams_, @placentaMD, T. Yeretsian, R. Ashraf, and the 204 participants from 27 countries who made this research possible. Our findings are now published in @JAMANetworkOpen.
Read the full paper here: https://t.co/Yhr11Vz9nH.
Our new research published in @JAMANetworkOpen developed a core outcome set and reporting checklist for vasa previa to improve harmonisation of data and clinical practice guidelines @McMasterU@LabFlourish@tashfromoz Read paper: https://t.co/1HlJXGr3PF
This study from the OROS group in @JAMANetworkOpen establishes a core outcome set and reporting checklist for vasa previa research, improving data consistency, evidence synthesis, and clinical guidelines to better support patients and families.
The study developed a core outcome set and reporting checklist for vasa previa to improve data harmonization, evidence synthesis, and clinical practice guidelines. https://t.co/Tpk1AFAH77
The study developed a core outcome set and reporting checklist for vasa previa to improve data harmonization, evidence synthesis, and clinical practice guidelines. https://t.co/Tpk1AFAH77
A new study from the OROS group in @JAMANetworkOpen marks a key step in maternal-fetal #medicine, introducing a standardized core outcome set and reporting checklist for vasa previa research to ensure patient-important outcomes guide care.
Learn more: https://t.co/JPKyZGHkAB.
A new study from the OROS group in @JAMANetworkOpen improves vasa previa research by standardizing outcomes and reporting. By uniting global perspectives, this work strengthens clinical evidence and ensures research aligns with patient needs.
Learn more: https://t.co/JPKyZGHkAB.
#DYK: Heart disease & stroke are the #1 cause of premature death in women in Canada?
With @BrainCanada & @CIHRIGH, we're closing the research gap by investing $10 million to support research focused on improving women's heart disease and stroke outcomes.
#InternationalWomensDay